Group 1 - The article reports significant declines in the stock prices of several Chinese concept stocks, with Mingzhu Freight experiencing the largest drop of 34.15% [1] - Other notable declines include Kaixin Automotive down 30.83%, INNO Holdings down 16.33%, Ridgetech down 15.97%, and Tongcheng Tongmei down 14.31% [1] - The trading volumes for these stocks varied, with Mingzhu Freight having a trading volume of 6.9956 million, while INNO Holdings had a much higher trading volume of 39.2023 million [1]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Mobile-Network Solutions (MNDR) is up 96% at $3.26 - PACS Group, Inc. (PACS) is up 44% at $24.37 - Cerence Inc. (CRNC) is up 28% at $10.16 - Magnera Corporation (MAGN) is up 26% at $10.07 - Oddity Tech Ltd. (ODD) is up 17% at $43.75 - Allot Ltd. (ALLT) is up 14% at $9.80 - Artiva Biotherapeutics, Inc. (ARTV) is up 14% at $3.88 - Kulicke and Soffa Industries, Inc. (KLIC) is up 13% at $40.22 - Fossil Group, Inc. (FOSL) is up 12% at $2.29 - NVIDIA Corporation (NVDA) is up 5% at $195.84 [3] Premarket Losers - Brera Holdings PLC (SLMT) is down 33% at $3.84 - Bath & Body Works, Inc. (BBWI) is down 14% at $18.04 - Cemtrex, Inc. (CETX) is down 11% at $3.20 - Atkore Inc. (ATKR) is down 9% at $60.00 - Gloo Holdings, Inc. (GLOO) is down 9% at $7.30 - SMX (Security Matters) Public Limited Company (SMX) is down 9% at $4.60 - Sonim Technologies, Inc. (SONM) is down 8% at $7.31 - Psyence Biomedical Ltd. (PBM) is down 7% at $2.56 - MMTec, Inc. (MTC) is down 6% at $2.00 - Ridgetech, Inc. (RDGT) is down 5% at $4.78 [4]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Shoulder Innovations, Inc. (SI) is up 14% at $13.01 [3] - BILL Holdings, Inc. (BILL) is up 11% at $52.14 [3] - On Holding AG (ONON) is up 8% at $38.24 [3] - CuriosityStream Inc. (CURI) is up 8% at $4.08 [3] - Clearwater Analytics Holdings, Inc. (CWAN) is up 7% at $19.80 [3] - Valhi, Inc. (VHI) is up 7% at $14.54 [3] - Beam Global (BEEM) is up 7% at $2.29 [3] - FGI Industries Ltd. (FGI) is up 6% at $5.66 [3] - The Honest Company, Inc. (HNST) is up 6% at $2.68 [3] - China Automotive Systems, Inc. (CAAS) is up 5% at $4.40 [3] Premarket Losers - Graphjet Technology (GTI) is down 22% at $3.02 [4] - Black Rock Coffee Bar, Inc. (BRCB) is down 10% at $21.90 [4] - Rain Enhancement Technologies Holdco, Inc. (RAIN) is down 9% at $4.90 [4] - Stereotaxis, Inc. (STXS) is down 9% at $2.59 [4] - Biohaven Ltd. (BHVN) is down 8% at $7.82 [4] - Epsium Enterprise Limited (EPSM) is down 7% at $3.15 [4] - Cycurion, Inc. (CYCU) is down 7% at $3.13 [4] - Galecto, Inc. (GLTO) is down 6% at $22.09 [4] - Anbio Biotechnology (NNNN) is down 6% at $21.68 [4] - Ridgetech, Inc. (RDGT) is down 5% at $3.46 [4]

Group 1 - The core point of the article highlights the significant stock price increases of several Chinese concept stocks, with Ridgetech leading the gains at 73.81% [1] - Ridgetech's latest price is $3.650, with a rise of $1.550 and a trading volume of 13.931 million [1] - Dingxin Holdings and Paiming Xincheng also saw substantial increases, with gains of 35.04% and 33.65% respectively [1] Group 2 - Dingxin Holdings' latest price is $1.580, with an increase of $0.410 and a trading volume of 2.3054 million [1] - Paiming Xincheng's latest price is $1.390, with a rise of $0.350 and a trading volume of 15.4776 million [1] - E-Jia Kuai Fu also experienced a notable increase of 20.58%, with a latest price of $0.9200 and a trading volume of 287,600 [1] Group 3 - Huami Technology recorded a gain of 17.19%, with a latest price of $26.250 and an increase of $3.850, along with a trading volume of 9.4049 million [1]

Group 1 - The top five gaining Chinese concept stocks at closing were Everbright Digital, Kebo Technology, Gulf Resources, Ridgetech, and Internet Technology Packaging, with significant percentage increases [1] - Everbright Digital saw a remarkable increase of 114.43%, closing at a price of 1.0700, with a trading volume of 83.05 million [1] - Kebo Technology experienced a rise of 59.57%, closing at 3.000, with a trading volume of 134 million [1] Group 2 - Gulf Resources increased by 40.10%, closing at 0.7201, with a trading volume of 834,000 [1] - Ridgetech rose by 31.54%, closing at 1.960, with a trading volume of 823,200 [1] - Internet Technology Packaging saw an increase of 31.02%, closing at 0.3417, with a trading volume of 34.48 million [1]

As filed with the U.S. Securities and Exchange Commission on September 25, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 (Exact name of registrant as specified in its charter) Cayman Islands 5122 Not Applicable (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) 5th Floor, Building 6, No. 100, 18th Street, Baiyang Sub-district, Qiantang Distr ...

As filed with the U.S. Securities and Exchange Commission on September 25, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Ridgetech, Inc. (Exact name of registrant as specified in its charter) Cayman Islands 5122 Not Applicable (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) 5th Floor ...

Group 1 - The top five gainers among Chinese concept stocks are Masonglory, Lanting Jishi, Xingfulai, K-Tech Solutions, and Ridgetech, with significant price increases ranging from 21.55% to 37.46% [1] - Masonglory (MSGY) saw a price increase of 37.46%, closing at 17.320 with a trading volume of 2.9466 million [1] - Lanting Jishi (LITB) experienced a 36.72% rise, closing at 1.750 with a trading volume of 1.307 million [1] Group 2 - Xingfulai (PAVS) increased by 27.92%, closing at 0.9319 with a trading volume of 236,700 [1] - K-Tech Solutions (KMRK) rose by 22.66%, closing at 1.570 with a trading volume of 349,500 [1] - Ridgetech (RDGT) had a gain of 21.55%, closing at 1.410 with a trading volume of 124,900 [1]

Financing and Investments - The company raised a total of $46.908 million from various financings between 2015 and 2025, in addition to $17.5 million raised during its IPO in April 2010[30]. - Following the Restructuring Transactions, the company expects to make equity investments in its subsidiaries rather than providing loans[31]. - The total amount invested in and lent to subsidiaries and historical VIEs is approximately $27.5 million and $8.7 million, respectively[30]. Revenue and Sales - Jiuxin Medicine's purchases from Jiuzhou Pharmacy ranged from approximately $70 million to $90 million annually over the last three fiscal years, with specific amounts of $87.12 million for Fiscal 2023, $76.99 million for Fiscal 2024, and $75.32 million for the eleven months ended February 28, 2025[32]. - The company has signed a three-year supply agreement with Jiuzhou Pharmacy, expecting Jiuxin Medicine to serve as a major supplier during this period[33]. - Sales to Jiuzhou Pharmacy currently account for over 60% of the company's revenue, and any disruption in this relationship could materially affect financial results[68]. - For the fiscal year ended March 31, 2025, total revenue decreased by approximately $4.02 million, or 3.2%, compared to the previous year[72]. - Revenue from the offline wholesale business was approximately $118.9 million for the year ended March 31, 2025, representing a decrease of $5.1 million, or 4.3%, compared to the prior year[73]. - Revenue from the online platform segment was approximately $1.1 million for the year ended March 31, 2025, reflecting contributions from Allright following its acquisition[74]. Regulatory and Compliance Risks - The company is subject to significant regulatory risks in China, which may affect its ability to conduct business and accept foreign investments[24]. - The PRC government imposes controls on the convertibility of RMB into foreign currencies, which may restrict the company's ability to pay dividends or satisfy foreign currency obligations[34]. - The Holding Foreign Companies Accountable Act requires foreign companies to certify they are not owned or controlled by a foreign government, with potential delisting from U.S. exchanges if compliance is not met[29]. - The company is subject to significant regulatory scrutiny in China, which could increase compliance costs and affect business operations[47]. - Compliance with privacy, data protection, and cybersecurity laws may result in significant costs and could adversely affect the company's reputation and financial condition[81]. - The company is required to maintain various permits and licenses, including a Drug Distribution Permit and GSP certification, which are subject to periodic renewal and reassessment by PRC governmental authorities[80]. - Compliance with China's new Data Security Law and Cyber Security Law may entail significant expenses and affect the company's business operations[98][99]. - The Cyberspace Administration of China has initiated actions against companies for alleged national security risks, which could impact the company's ability to operate and list securities abroad[100]. Competition and Market Conditions - The company faces significant competition in the pharmaceutical distribution industry in China, which is expected to intensify, potentially affecting revenue and profitability[50]. - The company may struggle to effectively grow its wholesale business organically and may not realize all anticipated benefits from acquisitions[45]. - The company is heavily dependent on third-party electronic platforms for online sales, which may restrict growth and affect financial performance[45]. - The wholesale pharmaceutical distribution industry in China is highly competitive, with significant competition from both regional and national distributors[186]. Operational Challenges - The company faces significant challenges in growing its wholesale business, including limited bargaining power and pricing volatility, which may negatively affect gross margins[69]. - The transition away from the retail pharmacy business may cause short-term operational inefficiencies and impact brand recognition, potentially affecting investor confidence[71]. - The company may face challenges in recovering accounts receivable from Jiuzhou Pharmacy and maintaining supply relationships, which are expected to generate substantial revenue in the near term[45]. - The company has not entered into any hedging transactions to mitigate foreign exchange rate fluctuations, which may expose it to additional risks[132]. Corporate Structure and Changes - The company completed the acquisition of Ridgeline and its subsidiary Allright on February 28, 2025, transitioning its focus to wholesale distribution and changing its name to Ridgetech, Inc.[59]. - The company no longer has any VIE within its corporate structure following the Restructuring Transactions[18]. - The company divested Jiuxin Investment and its controlled entities on February 28, 2025, eliminating the VIE structure from its corporate framework[200]. - The restructuring transactions were approved by shareholders on February 25, 2025, and closed on February 28, 2025[160]. Shareholder and Financial Information - The company has not paid any cash dividends to date and does not plan to distribute any in the foreseeable future[49]. - The company’s Chairman owns a substantial portion of outstanding shares, which may lead to conflicts of interest with other shareholders[49]. - The company was notified by Nasdaq for failing to maintain a minimum bid price of $1.00 per share, receiving a 180-day extension until December 12, 2023, to regain compliance[138]. - The closing price of the company's ordinary shares ranged from a low of $0.80 to a high of $2.80 over the past 52 weeks, indicating significant price volatility[143]. - The accumulated losses of the company's consolidated PRC entities amounted to $25.94 million as of March 31, 2025[189]. Economic and Geopolitical Factors - The company is significantly affected by international trade policies and disputes, particularly between the U.S. and China, which could harm its business and financial condition[116]. - Political and trade controversies may lead to a reduction in the price of the company's ordinary shares, with recent U.S. tariffs on imports potentially impacting operations[117]. - The ongoing geopolitical conflicts, such as the Russia-Ukraine war and tensions in the Middle East, could disrupt the global economy and affect the company's performance[118]. - The company's PRC subsidiaries may face limited access to new business opportunities due to trade relations, which could adversely impact their operations and financial performance[119].